量化布普伦诺芬在急性芬太尼暴露期间对死亡风险的潜在保护作用
Zheng Dai1, Marie A Abate2, Erin Winstanley3
1West Virginia University Health Affairs Institute, 64 Medical Center Dr., Morgantown, WV 26505, United States of America.
Journal of substance use and addiction treatment
|December 9, 2023
概括
布普伦诺芬 (BUP) 可能会防止致命的芬太尼过量服用. 这项研究发现,当BUP存在时,芬太尼度更高,这表明在阿片类药物使用障碍治疗中具有潜在的保护作用.
科学领域:
- 法医毒理学 法医毒理学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 布普伦诺芬是阿片类药物使用障碍 (OUD) 的关键治疗方法.
- 它在减轻致命芬太尼过量服用中的潜在作用需要量化.
- 芬太尼暴露造成过量死亡的重大风险.
研究的目的:
- 调查过量死亡中布普伦诺芬存在与芬太尼度之间的关联.
- 量化布诺芬在与芬太尼相关的死亡事件中的潜在保护作用.
- 为了确定影响过量服用 fentanyl 度的因素.
主要方法:
- 对3036名非故意芬太尼过量死亡者的横截面研究 (西弗吉尼亚州,2011-2020年).
- 血液中芬太尼度的分析,有或没有布普伦诺芬.
- 多变量回归模型调整人口统计,共毒剂和并发症;用于推断暴露时间的布普伦诺芬/诺布普伦诺芬比率.
主要成果:
- 在布普伦诺芬存在的死者中,芬太尼度的中位数高出65%.
- 布普伦诺芬的存在与芬太尼度增加了28.7% (B/N比率<1).
- 肥胖,男性性别,酒精和心血管疾病与较低的芬太尼水平有关;大麻和OUD历史与较高的水平有关.
结论:
- 持续使用布普伦诺芬可能会对致命的芬太尼暴露产生保护作用.
- 布普伦诺芬在OUD治疗中的作用至关重要,有可能减少因急性芬太尼暴露而导致死亡的风险.
- 这些发现强调了布普伦诺芬在打击与芬太尼相关死亡人数上升的重要作用.
相关概念视频
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
302
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
302
01:20Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
253
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
253
01:25Analgesia and Pain Management
628
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
628
01:19Depolarizing Blockers: Pharmocokinetics
327
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
327
01:11Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95